The Value of Early Site Selection in Type 2 Diabetes Trials

At Covance, they know that time is of the essence across their diabetes trials. Developing these trials in the most cost-efficient manner makes upfront planning crucial, but interrogating the best data resources to augment team expertise is a difficult task. Covance understands that delays to the development of a well-defined site list are costly, and that selection of the wrong investigators could cost a company crucial time to market. They use a variety of data sources to guide early site selection, honing in on the best possible sites and countries upfront to pre-identify the most effective sites for a trial. Their extensive data repositories allow them to create a master site list without the need for long, overly time-consuming feasibility questionnaires.